Liver disease research involves complex clinical trial considerations, particularly with evolving conditions such as metabolic dysfunction-associated steatohepatitis and alcoholic hepatitis, which present unique challenges including shifting disease definitions, complex biomarker-driven endpoints, and heterogeneous patient populations.
Read our infographic that explains the bespoke trial designs required for liver disease programs and the importance of operational strategies tailored to each indication’s complexity and maturity, which can only be achieved with a strategic CRO partner.
